Embla Medical hf. (CPH:EMBLA)

Embla Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	98.78	102.51	86.16	72.65	76.63	85.2
Cash & Short-Term Investments	98.78	102.51	86.16	72.65	76.63	85.2
Cash Growth	4.95%	18.97%	18.59%	-5.19%	-10.05%	-16.77%
Accounts Receivable	151.9	144.78	121.92	127.84	112.37	102.77
Other Receivables	-	8.76	7.36	5.52	4.36	2.76
Receivables	151.9	153.54	129.28	133.37	116.74	105.52
Inventory	161.91	165.62	143.1	136.23	132.13	103.99
Prepaid Expenses	-	19.28	22.63	17.66	14.5	14.05
Other Current Assets	54.36	17.06	15.78	16.07	8.86	9.48
Total Current Assets	466.94	458	396.96	375.98	348.85	318.23
Property, Plant & Equipment	234.22	242.73	199.63	186.06	179.32	182.08
Long-Term Investments	32.12	29.6	21.22	23.44	17.08	13.65
Goodwill	824.99	835.56	776.31	690.86	680.4	644.15
Other Intangible Assets	101.69	106.91	96.65	65.84	62	58.84
Long-Term Deferred Tax Assets	53.65	55.38	46.37	41.89	37.32	27.04
Other Long-Term Assets	3.85	2.32	1.85	1.63	0.39	2.92
Total Assets	1,717	1,730	1,539	1,386	1,325	1,247

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	39.22	32.83	27.28	30.75	28.65	26.72
Accrued Expenses	51.98	91.52	76.73	78.86	63.35	62.49
Current Portion of Long-Term Debt	154.94	67.68	28.62	21.53	62.07	46.04
Current Portion of Leases	27.33	28.22	24.14	21.79	24.77	21.24
Current Income Taxes Payable	19.93	21.32	18.31	12.14	11.01	7.35
Current Unearned Revenue	-	3.01	2.72	2.84	3.32	3.37
Other Current Liabilities	79.43	65	31.5	28.28	43.84	19.24
Total Current Liabilities	372.84	309.57	209.28	196.2	237.01	186.46
Long-Term Debt	205.16	292.17	328.75	311.8	277.71	262.19
Long-Term Leases	146.54	153.5	118.28	112.61	116.38	118.67
Long-Term Unearned Revenue	11.27	11.35	8.59	7.28	6.04	6.25
Long-Term Deferred Tax Liabilities	38.25	39.79	37.48	28.78	29.6	29.03
Other Long-Term Liabilities	17.37	28.31	55.88	24.02	23.12	17.72
Total Liabilities	791.43	834.69	758.27	680.68	689.85	620.32

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	4.82	4.84	4.83	4.78	4.78	4.8
Additional Paid-In Capital	85.5	93.63	88.64	61.48	61.43	70.78
Retained Earnings	887.01	843.84	760.38	700.93	641.23	593.2
Comprehensive Income & Other	-56.7	-51.76	-76.66	-65.31	-71.74	-47.18
Total Common Equity	920.63	890.55	777.19	701.88	635.7	621.59
Minority Interest	5.4	5.25	3.51	3.12	-0.19	5.01
Shareholders' Equity	926.03	895.8	780.7	705.01	635.51	626.6
Total Liabilities & Equity	1,717	1,730	1,539	1,386	1,325	1,247

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	533.97	541.57	499.79	467.73	480.92	448.15
Net Cash (Debt)	-435.2	-439.06	-413.63	-395.08	-404.29	-362.95
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.01	-1.03	-0.97	-0.94	-0.97	-0.86
Filing Date Shares Outstanding	425.89	427.77	427.3	420.3	420.29	422.26
Total Common Shares Outstanding	425.89	427.77	426.93	420.3	420.29	422.26
Working Capital	94.1	148.43	187.67	179.78	111.84	131.78
Book Value Per Share	2.16	2.08	1.82	1.67	1.51	1.47
Tangible Book Value	-6.05	-51.92	-95.77	-54.81	-106.7	-81.4
Tangible Book Value Per Share	-0.01	-0.12	-0.22	-0.13	-0.25	-0.19
Buildings	-	-	-	-	2.26	1.61
Machinery	131.27	125.86	109	101.68	129.71	135.77
Leasehold Improvements	63.74	62.75	51.27	42.81	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 27, 2026

Data Sources Report a data error